Mitigating inflammation, inhibiting immunosenescence, and eliminating senescent cells could be promising strategies for enhancing vaccine responses in older people. The mTOR signalling pathway greatly ...
The graft versus host disease market is experiencing significant growth, driven by the ongoing adoption of branded therapies such as JAKAFI, IMBRUVICA, ORENCIA, and REZUROCK compared to off-label ...
It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and ...